ELVN

ENLIVEN THERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

ENLIVEN THERAPEUTICS INC (ELVN) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$173.85M; the largest are Ken Griffin, Baker Bros. Advisors, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 added. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Heating up

Common-stock holders41 also report options

Congress trades0

Price$46.01vs quarter-end-9.34%

Sectors0

This quarter's moves

New1

Added2

Trimmed / sold0

Top holder

Ken Griffin

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $45.94M0.2% of portfolio905,1912026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$45.94M	905,191	0.2%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinPUT—

Value $3.65M— of portfolio72,0002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinPUT	2026 Q2	$3.65M	72,000	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.